AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, A. Y.-M.
Right arrow Articles by Woo, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, A. Y.-M.
Right arrow Articles by Woo, J.
Agricola
Right arrow Articles by Wang, A. Y.-M.
Right arrow Articles by Woo, J.
American Journal of Clinical Nutrition, Vol. 87, No. 6, 1631-1638, June 2008
© 2008 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study1,2,3

Angela Yee-Moon Wang, Christopher Wai-Kei Lam, John E Sanderson, Mei Wang, Iris Hiu-Shuen Chan, Siu-Fai Lui, Mandy Man-Mei Sea and Jean Woo

1 From the Departments of Medicine and Therapeutics (AY-MW, JES, MW, S-FL, MM-MS, and JW) and Chemical Pathology (CW-KL and IH-SC), The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong

Background:Patients with kidney disease are at high risk of developing 25-hydroxyvitamin D [25(OH)D] deficiency.

Objective:We studied the association between serum 25(OH)D status and clinical outcomes of chronic peritoneal dialysis patients.

Design:We measured serum 25(OH)D concentrations in 230 prevalent peritoneal dialysis patients and then followed these patients prospectively for 3 y or until death.

Results:Serum 25(OH)D was deficient or insufficient (ie, <75nmol/L) in 87% of the patients. Adjusting for clinical and demographic factors, every 1-unit increase in log-transformed serum 25(OH)D was associated with a 44% reduction in the hazard of fatal or nonfatal cardiovascular events (95% CI: 0.35, 0.91; P = 0.018). However, the association was gradually lost when additional adjustment was made in a stepwise fashion for residual glomerular filtration rate (P = 0.078) and echocardiographic measures (P = 0.39). Kaplan-Meier estimates showed a significantly greater fatal or nonfatal cardiovascular event-free survival probability among patients with serum 25(OH)D > 45.7 nmol/L (median) than among patients with concentrations ≤ 45.7 nmol/L (P = 0.004). In addition, patients with 25(OH)D > 45.7 nmol/L had a significantly higher cardiovascular event-free survival probability than did patients with 25(OH)D ≤ 45.7 nmol/L in the stratified analysis for patients with left ventricular mass index less than the median (P = 0.013) or normal systolic function (P = 0.005).

Conclusions:A lower serum 25(OH)D concentration was associated with an increased risk of cardiovascular events in chronic peritoneal dialysis patients. Furthermore, serum 25(OH)D status appeared to show a differential influence on the cardiovascular outcomes of peritoneal dialysis patients depending on the degree of left ventricular hypertrophy and systolic dysfunction.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
R. Thadhani
Is Calcitriol Life-Protective for Patients with Chronic Kidney Disease?
J. Am. Soc. Nephrol., November 1, 2009; 20(11): 2285 - 2290.
[Full Text] [PDF]


Home page
CJASNHome page
J. N. Artaza, R. Mehrotra, and K. C. Norris
Vitamin D and the Cardiovascular System
Clin. J. Am. Soc. Nephrol., September 1, 2009; 4(9): 1515 - 1522.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
D. V. Barreto, F. C. Barreto, S. Liabeuf, M. Temmar, F. Boitte, G. Choukroun, A. Fournier, and Z. A. Massy
Vitamin D Affects Survival Independently of Vascular Calcification in Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., June 1, 2009; 4(6): 1128 - 1135.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
B. Piraino, E. Minev, J. Bernardini, and F. H. Bender
DOES EXPERIENCE WITH PD MATTER?
Perit. Dial. Int., May 1, 2009; 29(3): 256 - 261.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Fourtounas and J. G Vlachojannis
Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients
Am. J. Clinical Nutrition, January 1, 2009; 89(1): 436 - 436.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition